Nordhealth AS carries a market capitalization of 1.88B, placing it among publicly traded companies globally. Its enterprise value stands at 179.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.88B |
| Enterprise Value | 179.49M |
Nordhealth AS currently has 78.81M shares outstanding.
| Shares Outstanding | 78.81M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | 3.75 |
| PB Ratio | N/A |
| P/TBV Ratio | 18.70 |
| P/FCF Ratio | 54.14 |
| P/OCF Ratio | -127.68 |
| EV / Sales | 3.46 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 46.02 |
Nordhealth AS maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.65 |
| Quick Ratio | 1.03 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -49.16 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -19.28 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | 461,000.00 |
| Effective Tax Rate | N/A |
Nordhealth AS's stock has declined approximately -41.08911% over the past 52 weeks. The 50-day moving average sits at 25.44, while the 200-day moving average is 31.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | -41.08911% |
| 50-Day Moving Average | 25.44 |
| 200-Day Moving Average | 31.18 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Nordhealth AS generated 51.83M in revenue and converted that into -15.21M in net income, yielding earnings per share of -0.19. EBITDA reached -14.70M, while operating income came in at -14.70M.
| Revenue | 51.83M |
| Gross Profit | 41.44M |
| Operating Income | -14.70M |
| Pretax Income | -14.74M |
| Net Income | -15.21M |
| EBITDA | -14.70M |
| EBIT | -14.70M |
| Earnings Per Share (EPS) | -0.19 |
| Cash & Cash Equivalents | 14.96M |
| Total Debt | N/A |
| Net Debt | -8.28M |
| Equity (Book Value) | N/A |
| Book Value Per Share | N/A |
| Working Capital | 9.50M |
Nordhealth AS produced -1.52M in operating cash flow over the past twelve months. After subtracting -5.11M in capital expenditures, free cash flow totaled -6.64M - equivalent to -0.08 per share.
| Operating Cash Flow | -1.52M |
| Capital Expenditures | -5.11M |
| Free Cash Flow | -6.64M |
| FCF Per Share | -0.08 |
Nordhealth AS operates with a gross margin of 79.96, reflecting its pricing power and cost economics. The operating margin of -28.36 and net profit margin of -29.34 provide insight into operational efficiency.
| Gross Margin | 79.96 |
| Operating Margin | -28.36 |
| Pretax Margin | -28.45 |
| Profit Margin | -29.34 |
| EBITDA Margin | -28.36 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.46 |
| FCF Yield | 1.85 |
Nordhealth AS posts an Altman Z-Score of 8.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.55 |